What SEC filings are tracked for $GNVR (Genvor Inc)?

Position Tracker indexes 1 SEC EDGAR filings for Genvor Inc ($GNVR), including 0 Form 10-K annual reports, 0 Form 10-Q quarterly reports, 1 Form 8-K material event disclosures, and 0 Form 4 insider buying and selling filings.

When was the most recent $GNVR (Genvor Inc) SEC filing?

The latest tracked SEC EDGAR filing for Genvor Inc ($GNVR) was filed on October 26, 2026, with 0 high-impact or featured filings flagged by Position Tracker's AI analysis.

$GNVR SEC EDGAR Filings Hub 1 Filing

$GNVR · Genvor Inc SEC Filings

Position Tracker tracks 1 SEC EDGAR filings for Genvor Inc ($GNVR) from October 26, 2026 through October 26, 2026, including 0 Form 10-K annual reports, 0 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.

Check $GNVR portfolio concentration → View $GNVR Congress trades → Research $GNVR stock → All SEC filings →

Total Filings1

10-K / 10-Q Reports0

8-K Material Events1

Form 4 Insider0

High-Impact0

Latest FilingOctober 26, 2026

Browse SEC Filings by Form Type

Form 4 Form 8-K Form 10-K Form 10-Q Schedule 13D/13G Form 13F Form S-1 Form 6-K

Latest $GNVR SEC Filings & AI Summaries (1)

$GNVR Form 8-K Impact 6/10 M&A / Strategic

October 26, 2026

$GNVR 8-K — Genvor Inc

A founder-CSO assigning core IP to the company eliminates a major intangible risk for a pre-revenue biotech — without it, the company's lead asset base was not fully owned.

Read AI filing analysis → SEC.gov filing ↗

$GNVR · Genvor Inc SEC Filings

$GNVR 8-K — Genvor Inc

Get real-time alerts when $GNVR files a new 10-K, 10-Q, 8-K, or Form 4.